New Mexico Educational Retirement Board cut its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Rating) by 4.6% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,765 shares of the pharmacy operator's stock after selling 1,900 shares during the quarter. New Mexico Educational Retirement Board's holdings in Walgreens Boots Alliance were worth $1,507,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Cetera Investment Advisers boosted its position in shares of Walgreens Boots Alliance by 6.2% in the fourth quarter. Cetera Investment Advisers now owns 160,825 shares of the pharmacy operator's stock worth $8,389,000 after buying an additional 9,356 shares during the period. Centiva Capital LP acquired a new stake in shares of Walgreens Boots Alliance in the fourth quarter worth $930,000. CIBC World Markets Inc. boosted its position in shares of Walgreens Boots Alliance by 2.6% in the fourth quarter. CIBC World Markets Inc. now owns 279,368 shares of the pharmacy operator's stock worth $14,572,000 after buying an additional 7,001 shares during the period. Cary Street Partners Investment Advisory LLC acquired a new stake in shares of Walgreens Boots Alliance in the fourth quarter worth $353,000. Finally, MML Investors Services LLC boosted its position in shares of Walgreens Boots Alliance by 56.4% in the fourth quarter. MML Investors Services LLC now owns 46,142 shares of the pharmacy operator's stock worth $2,407,000 after buying an additional 16,640 shares during the period. 57.33% of the stock is owned by institutional investors.

Walgreens Boots Alliance Price Performance

NASDAQ WBA opened at $31.40 on Monday. Walgreens Boots Alliance, Inc. has a fifty-two week low of $31.23 and a fifty-two week high of $55.00. The stock's 50-day moving average is $36.70 and its two-hundred day moving average is $40.58. The company has a debt-to-equity ratio of 0.35, a current ratio of 0.78 and a quick ratio of 0.43. The firm has a market cap of $27.14 billion, a P/E ratio of 5.06, a price-to-earnings-growth ratio of 1.36 and a beta of 0.64.

Walgreens Boots Alliance Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, September 9th. Stockholders of record on Friday, August 19th were paid a $0.48 dividend. The ex-dividend date of this dividend was Thursday, August 18th. This is a positive change from Walgreens Boots Alliance's previous quarterly dividend of $0.48. This represents a $1.92 dividend on an annualized basis and a dividend yield of 6.11%. Walgreens Boots Alliance's payout ratio is presently 30.97%.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on WBA. Deutsche Bank Aktiengesellschaft decreased their target price on Walgreens Boots Alliance from $44.00 to $38.00 and set a "hold" rating for the company in a research report on Thursday, September 22nd. Cowen cut their price objective on Walgreens Boots Alliance to $49.00 in a report on Thursday, June 9th. JPMorgan Chase & Co. cut their price objective on Walgreens Boots Alliance from $52.00 to $45.00 and set a "neutral" rating for the company in a report on Friday, July 8th. Barclays cut their price objective on Walgreens Boots Alliance from $50.00 to $45.00 and set an "equal weight" rating for the company in a report on Friday, June 24th. Finally, Credit Suisse Group cut their price objective on Walgreens Boots Alliance from $52.00 to $43.00 and set a "neutral" rating for the company in a report on Friday, July 1st. One research analyst has rated the stock with a sell rating and nine have assigned a hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $45.75.

Walgreens Boots Alliance Profile

(Get Rating)

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Recommended Stories

• Get a free copy of the StockNews.com research report on Walgreens Boots Alliance (WBA)
• Archer Daniels Midland: Dividend Hero With 49 Years Of Increases
• Will Fully Autonomous Tractors Make Deere the Tesla of Farming?
• Magna International is Your Auto and EV One-Stop Shop Stock
• EV Battery Maker Freyr Set For Major Global Expansion
• MarketBeat: Week in Review 9/26 – 9/30

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.